Tucson-based Critical Path Institute emerging as top drug-research organization

President and CEO Dr. Martha Brumfield was recently interviewed by the Arizona Daily Star for a profile on C-Path published February 11. Dr. Brumfield discusses C-Path’s local ties,expanding global reach, and its recent successes, as well as its groundbreaking collaborative research model. The story outlines the work of C-Path’s consortia in the areas of biomarker discovery, patient-reported outcome instruments, disease modeling, and data collaboration, and features commentary by a PSTC collaborator at Pfizer and an INC collaborator at the Floating Hospital for Children at Tufts Medical Center. The opening sentences of the article sum up the impact of C-Path: “The Tucson-based Critical Path Institute has no laboratories, no drug chemists, no patent lawyers. Yet the nonprofit is arguably one of the most important emerging drug-research organizations in the nation, if not the world.” Read the entire story at http://tucson.com/business/tucson-based-critical-path-institute-emerging-as-top-drug-research/article_8de7783c-de5b-59e1-a626-356db11097ef.html.